Advertisement

Topics

ViroLogic Company Profile

12:43 EST 21st November 2017 | BioPortfolio

ViroLogic, a privately held South San Francisco-based biotechnology company, is a leader in the development of novel therapy guidance tools to enable patients, physicians, and medical reimbursers to make rational treatment decisions in the management of viral diseases. The company's proprietary technology is also being used in the fields of viral pharmacogenomics to identify, analyze, and select new drug candidates for treating viral diseases and cancer, and in disease management through the development of therapy guidance algorithms to guide patient therapy. ViroLogic sales representatives have been in the field since November 1999 raising awareness among HIV-treating physicians of phenotypic testing and its benefits.

Location

270 East Grand Avenue
South San Francisco
CA
94080
United States of America


News Articles [14 Associated News Articles listed on BioPortfolio]

J&J reports positive results for HIV regimen

Patients taking a once-daily tablet comprised of darunavir and a regimen of Gilead drugs overall demonstrated low virologic rebound rates and high virologic suppression.

Cash Incentives Enhance HIV Outcomes

Virologic suppression rates improved in urban HIV clinics at a cost of less than US$300 per patient annually.

Sustained Response with HCV Combo Drug in CKD

(MedPage Today) -- Patients with both diseases had virologic response and no failure

Glecaprevir plus Pibrentasvir for Genotype 3 Hepatitis C Virus Infection

High rates of sustained virologic response were achieved with 12 to 16 weeks of treatment in this difficult-to-treat population.

Drug Combo Promising for HCV Infection in Patients With Advanced CKD

Researchers report a high rate of sustained virologic response after 12 weeks of treatment with a ribavirin-free co-formulation of glecaprevir and pibrentasvir.

Risk for Liver Cancer After Hepatitis C Treatment with Direct-Acting Antivirals

Cancer incidence was lower among patients who achieved sustained virologic response versus those who did not.

Immediate Antiretroviral Therapy Improves Retention and Outcomes

Initiating antiretroviral therapy (ART) on the same day as HIV testing is feasible and leads to improved retention and virologic suppression in patients with early HIV disease, according to a trial in...

Janssen Announces Phase 3 Pivotal Study Results for Darunavir-Based Complete Treatment Regimen

- Interim results from the pivotal EMERALD trial presented during an oral session at the International AIDS Society Conference show a low cumulative virologic rebound rate and a h...

Drugs and Medications [15 Associated Drugs and Medications listed on BioPortfolio]

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use Ribavirin safely and effectively. See full prescribing information for Ribavirin.Ribavirin Capsules Initial U.S. Approval: 1998

Ribavirin [American Health Packaging]

These highlights do not include all the information needed to use Ribavirin safely and effectively. See full prescribing information for Ribavirin.Ribavirin Capsules Initial U.S. Approval: 1998

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin capsules safely and effectively. See full prescribing information for ribavirin capsules. Initial U.S. Approval: 1998

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin capsules safely and effectively. See full prescribing information for ribavirin capsules. Initial U.S. Approval: 1998

Selzentry [Pfizer Laboratories Div Pfizer Inc]

These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) TabletsInitial U.S. Approval:...

PubMed Articles [71 Associated PubMed Articles listed on BioPortfolio]

Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil.

Pharmacy adherence measures such as pharmacy dispensing ratios (PDRs) have previously been shown to be predictive of virologic outcomes. We aimed to determine the optimal interval of PDR assessment fo...

Prescription Opioid Use is Associated with Virologic Failure in People Living with HIV.

Prescription opioid misuse is a rising epidemic in the U.S., and people living with HIV are at increased risk. We assessed the association between prescription opioid use and virologic failure in HIV+...

A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS.

Assess whether a commitment contract informed by behavioral economics leads to persistent virologic suppression among HIV-positive patients with poor antiretroviral therapy (ART) adherence.

Virologic Response to Early Antiretroviral Therapy in HIV-Infected Infants: Evaluation After Two Years of Treatment in the Pediacam Study, Cameroon.

Little is known about virologic responses to early antiretroviral therapy (ART) in HIV-infected infants in resource-limited settings. We estimated the probability of achieving viral suppression within...

Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.

Poorer virologic response to nevirapine- versus efavirenz-based antiretroviral therapy (ART) has been reported in adult systematic reviews and pediatric studies.

Clinical Trials [240 Associated Clinical Trials listed on BioPortfolio]

Structured Treatment Interruption for HIV Patients With Virologic Failure

The purpose of this study is to assess the virologic impact of switching treatment-experienced HIV-infected patients with virologic failure to a salvage regimen with or without a 12 week S...

Study to Evaluate the Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in HIV-infected Subjects Evidencing Virologic Suppression

The main purpose is to explore whether atazanavir/ritonavir (ATV/RTV) single enhanced protease inhibitor therapy can maintain virologic suppression without a marked increase in virologic f...

EXtended Therapy in Hepatitis C Genotype 3 Infected Patients

The purpose of this study is to evaluate the effect of 48 vs 24 weeks of treatment with Peginterferon alfa-2b plus weight-based ribavirin on Sustained Virologic Response (SVR) and relapse ...

Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy

To elucidate the relationship between virologic risk factors and immunologic and clinical progression in patients receiving monotherapy in protocol ACTG 175, and to compare new treatment r...

Study of Nitazoxanide in the Treatment of Chronic Hepatitis C

This study will evaluate the effect of treatment with 24 weeks nitazoxanide monotherapy on end of treatment virologic response, sustained virologic response, reduction of quantitative seru...

Companies [2 Associated Companies listed on BioPortfolio]

ViroLogic

ViroLogic, a privately held South San Francisco-based biotechnology company, is a leader in the development of novel therapy guidance tools to enable patients, physicians, and medical reimbursers to m...

Adenosine Therapeutics,LLC

Adenosine Therapeutics (AT), located in Charlottesville, VA, is a drug discovery and development company that was co-founded in 1999 by University of Virginia (UVa) Professor, Joel Linden and entrepre...

More Information about "ViroLogic" on BioPortfolio

We have published hundreds of ViroLogic news stories on BioPortfolio along with dozens of ViroLogic Clinical Trials and PubMed Articles about ViroLogic for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ViroLogic Companies in our database. You can also find out about relevant ViroLogic Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record